These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 5576217)

  • 21. The excretion of 5,5-diphenylhydantoin in the semen of man and the rabbit comparison with plasma concentrations of the drug.
    Leger RM; Swanson BN; Gerber N
    Proc West Pharmacol Soc; 1977; 20():69-72. PubMed ID: 896862
    [No Abstract]   [Full Text] [Related]  

  • 22. The effect of diphenylhydantoin on the microbial assay of serum folate.
    Foster N; Campbell B
    Clin Biochem; 1976 Feb; 9(1):22-3. PubMed ID: 813913
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interactions between folate metabolism, phenytoin metabolism, and liver microsomal cytochrome P450.
    Billings RE
    Drug Nutr Interact; 1984; 3(1):21-32. PubMed ID: 6510238
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phenytoin-folic acid interaction: a lesson to be learned.
    Seligmann H; Potasman I; Weller B; Schwartz M; Prokocimer M
    Clin Neuropharmacol; 1999; 22(5):268-72. PubMed ID: 10516876
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of pregnancy and folic acid on phenytoin metabolism by rat liver microsomes.
    Blake DA; Collins JM; Miyasaki BC; Cohen F
    Drug Metab Dispos; 1978; 6(3):246-50. PubMed ID: 26544
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CSF and serum folic acid and protein changes with diphenylhydantoin treatment: laboratory and clinical correlations.
    Boykin ME; Hooshmand H
    Neurology; 1970 Apr; 20(4):403. PubMed ID: 5535043
    [No Abstract]   [Full Text] [Related]  

  • 27. Clinical implications of certain aspects of diphenylhydantoin metabolism.
    Bochner F; Hooper W; Tyrer J; Eadie M
    Proc Aust Assoc Neurol; 1973; 9():171-8. PubMed ID: 4719398
    [No Abstract]   [Full Text] [Related]  

  • 28. Effect of diphenylhydantoin on cortisol kinetics in humans.
    Choi Y; Thrasher K; Werk EE; Sholiton LJ; Olinger C
    J Pharmacol Exp Ther; 1971 Jan; 176(1):27-34. PubMed ID: 4936459
    [No Abstract]   [Full Text] [Related]  

  • 29. Pharmacokinetics and distribution of diphenylhydantoin in kittens.
    Tobin T; Dirdjosudjono S; Baskin SI
    Am J Vet Res; 1973 Jul; 34(7):951-4. PubMed ID: 4720683
    [No Abstract]   [Full Text] [Related]  

  • 30. Urinary excretion of diphenylhydantoin metabolites in newborn infants.
    Rane A
    J Pediatr; 1974 Oct; 85(4):543-5. PubMed ID: 4475101
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The significance of cumulation and elimination for the determination of Phenytoin (diphenylhydantoin)].
    Remmer H; Hirschmann J; Greiner I
    Dtsch Med Wochenschr; 1969 Jun; 94(24):1265-72. PubMed ID: 5771073
    [No Abstract]   [Full Text] [Related]  

  • 32. Brain folate concentration in folate-deficient rats receiving diphenylhydantoin.
    Allen CD; Klipstein FA
    Neurology; 1970 Apr; 20(4):403. PubMed ID: 5535044
    [No Abstract]   [Full Text] [Related]  

  • 33. Folic acid deficiency in neoplastic disease.
    Spector I; Hutter AM
    Am J Med Sci; 1966 Oct; 252(4):419-23. PubMed ID: 5922489
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of folic acid on the pharmacokinetics of acutely administered phenytoin in pregnant and nonpregnant rats.
    Chou RC; Levy G
    J Pharm Sci; 1984 Aug; 73(8):1180-2. PubMed ID: 6491931
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of phenobarbital or SKF 525A pretreatment on diphenylhydantoin disposition in pregnant mice.
    Harbison RD; Becker BA
    Toxicol Appl Pharmacol; 1971 Dec; 20(4):573-81. PubMed ID: 5143597
    [No Abstract]   [Full Text] [Related]  

  • 36. Inhibition of diphenylhydantoin elimination by its major metabolite.
    Ashley JJ; Levy G
    Res Commun Chem Pathol Pharmacol; 1972 Sep; 4(2):297-306. PubMed ID: 5074529
    [No Abstract]   [Full Text] [Related]  

  • 37. The effect of different sulfonamides on phenytoin metabolism in man.
    Hansen JM; Kampmann JP; Siersbaek-Nielsen K; Lumholtz IB; Arrøe M; Abildgaard U; Skovsted L
    Acta Med Scand Suppl; 1979; 624():106-10. PubMed ID: 284708
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of sulphonylureas (tolazamide, tolbutamide and chlorpropamide) on the metabolism of diphenylhydantoin in the rat.
    Wesseling H; Thurkow I; Mulder G
    Biochem Pharmacol; 1973 Dec; 22(23):3033-40. PubMed ID: 4761563
    [No Abstract]   [Full Text] [Related]  

  • 39. Phenytoin-folic acid interaction.
    Lewis DP; Van Dyke DC; Willhite LA; Stumbo PJ; Berg MJ
    Ann Pharmacother; 1995; 29(7-8):726-35. PubMed ID: 8520091
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Altered protein binding of diphenylhydantoin in uremic plasma.
    Blum MR; Riegelman S; Becker CE
    N Engl J Med; 1972 Jan; 286(2):109. PubMed ID: 5006870
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.